Literature DB >> 3742218

Bradykinin-induced intracellular Ca2+ elevation in neuroblastoma X glioma hybrid NG108-15 cells; relationship to the action of inositol phospholipids metabolites.

T Osugi, S Uchida, T Imaizumi, H Yoshida.   

Abstract

The effect of bradykinin on the intracellular Ca2+ concentration ([Ca2+]i) in NG108-15 cells was studied using a Ca2+ indicator quin 2. Bradykinin induced two phases of change in [Ca2+]i. Bradykinin induced a spike phase of [Ca2+]i increase which was detectable within 15 s and decayed to near-basal concentration in 3 min and then a prolonged plateau phase of [Ca2+]i increase which continued for 15 min. The bradykinin-induced spike phase was not diminished by decreasing extracellular Ca2+ concentration ([Ca2+]o) to 1 microM. On the contrary, the plateau phase was dependent on [Ca2+]o and inhibited by Ca2+ blockers, verapamil (50 microM), nifedipine (1 microM). The iontophoretic injection of inositol-trisphosphate (IP3) into the single cell induced the increase of [Ca2+]i, which was independent of [Ca2+]o. These results indicate that the bradykinin-induced spike phase is mediated by the release of intracellular Ca2+ stores induced by IP3, while the plateau phase is mediated by influx of extracellular Ca2+ probably through voltage-sensitive Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742218     DOI: 10.1016/0006-8993(86)90258-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Intracellular Mg2+ inhibits the IP3-activated IK(Ca) in NG108-15 cells. [Why intracellular citrate can be useful for recording IK(Ca)].

Authors:  J Robbins; R Cloues; D A Brown
Journal:  Pflugers Arch       Date:  1992-03       Impact factor: 3.657

2.  The role of bradykinin in the etiology of vasogenic brain edema and perilesional brain dysfunction.

Authors:  I R Whittle; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  Hypothermia reduces calcium entry via the N-methyl-D-aspartate and ryanodine receptors in cultured hippocampal neurons.

Authors:  Kristin F Phillips; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2012-10-17       Impact factor: 4.432

4.  Desensitization and recovery of muscarinic and histaminergic Ca2+ mobilization in 1321N1 astrocytoma cells.

Authors:  P M McDonough; J H Eubanks; J H Brown
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

5.  Inositol 1,4,5-trisphosphate and diacylglycerol mimic bradykinin effects on mouse neuroblastoma x rat glioma hybrid cells.

Authors:  D A Brown; H Higashida
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

6.  Ca(2+)-dependent K+ channel activity in rat glioma cells induced by bradykinin stimulation and by inositol 1,4,5-trisphosphate injection.

Authors:  F J Binmöller; G Reiser
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

7.  Identification of a B2-bradykinin receptor linked to phospholipase C and inhibition of dopamine stimulated cyclic AMP accumulation in the human astrocytoma cell line D384.

Authors:  A J Balmforth; F E Parkinson; N Altiok; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

8.  Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture.

Authors:  Nisha Nagarkatti; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Neurosci Lett       Date:  2008-03-21       Impact factor: 3.046

9.  Sodium channel activation does not alter lipid metabolism in cultured neuroblastoma cells.

Authors:  T N Glanville; M W Spence; H W Cook; F B Palmer
Journal:  Neurochem Res       Date:  1988-11       Impact factor: 3.996

10.  Membrane current responses of NG108-15 mouse neuroblastoma x rat glioma hybrid cells to bradykinin.

Authors:  D A Brown; H Higashida
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.